LITHIUM CARBONATE tablet

Pajjiż: Stati Uniti

Lingwa: Ingliż

Sors: NLM (National Library of Medicine)

Ingredjent attiv:

LITHIUM CARBONATE (UNII: 2BMD2GNA4V) (LITHIUM CATION - UNII:8H8Z5UER66)

Disponibbli minn:

STAT RX USA LLC

INN (Isem Internazzjonali):

LITHIUM CARBONATE

Kompożizzjoni:

LITHIUM CARBONATE 300 mg

Rotta amministrattiva:

ORAL

Tip ta 'preskrizzjoni:

PRESCRIPTION DRUG

Indikazzjonijiet terapewtiċi:

Lithium toxicity is closely related to serum lithium levels, and can occur at doses close to therapeutic levels. Facilities for prompt and accurate serum lithium determinations should be available before initiating therapy (see DOSAGE AND ADMINISTRATION). Each tablet for oral administration contains: Lithium Carbonate . . . . . . . . . . 300 mg Each capsule for oral administration contains: Lithium Carbonate . . . . . . . . . . 150 mg, 300 mg or 600 mg Each 5 mL of solution for oral administration contains: Lithium ion (Li+) . . . . . . . . . . 8 mEq (equivalent to amount of lithium in 300 mg of lithium carbonate), alcohol 0.3% v/v. The capsules contain talc, gelatin, FD and C Red No. 40, titanium dioxide, and the imprinting ink contains FD and C Blue No. 2, FD and C Yellow No. 6, FD and C Red No. 40, synthetic black iron oxide, and pharmaceutical glaze. The tablets contain calcium stearate, microcrystalline cellulose, povidone, sodium lauryl sulfate, and sodium starch glycolate. The solution contain

L-istatus ta 'awtorizzazzjoni:

New Drug Application

Karatteristiċi tal-prodott

LITHIUM CARBONATE - LITHIUM CARBONATE TABLET
STAT RX USA LLC
----------
WARNING
Lithium toxicity is closely related to serum lithium levels, and can
occur at doses close to therapeutic
levels. Facilities for prompt and accurate serum lithium
determinations should be available before
initiating therapy (see DOSAGE AND ADMINISTRATION).
DESCRIPTION
Each tablet for oral administration contains:
Lithium Carbonate . . . . . . . . . . 300 mg
Each capsule for oral administration contains:
Lithium Carbonate . . . . . . . . . . 150 mg, 300 mg or 600 mg
Each 5 mL of solution for oral administration contains:
Lithium ion (Li+) . . . . . . . . . . 8 mEq
(equivalent to amount of lithium in 300 mg of lithium carbonate),
alcohol 0.3% v/v.
Inactive Ingredients:
The capsules contain talc, gelatin, FD and C Red No. 40, titanium
dioxide, and the imprinting ink
contains FD and C Blue No. 2, FD and C Yellow No. 6, FD and C Red No.
40, synthetic black iron
oxide, and pharmaceutical glaze. The tablets contain calcium stearate,
microcrystalline cellulose,
povidone, sodium lauryl sulfate, and sodium starch glycolate. The
solution contains alcohol, sorbitol,
flavoring, water, and other ingredients.
Lithium Oral Solution is a palatable oral dosage form of lithium ion.
It is prepared in solution from
lithium hydroxide and citric acid in a ratio approximately di-lithium
citrate.
Lithium is an element of the alkali-metal group with atomic number 3,
atomic weight 6.94, and an
emission line at 671 nm on the flame photometer.
The empirical formula for Lithium Citrate is C H
Li
O ; molecular weight 209.92. Lithium acts as an
antimanic.
Lithium Carbonate is a white, light, alkaline powder with molecular
formula Li
CO and molecular
weight 73.89.
CLINICAL PHARMACOLOGY
Preclinical studies have shown that lithium alters sodium transport in
nerve and muscle cells and effects
a shift toward intraneuronal metabolism of catecholamines, but the
specific biochemical mechanism of
lithium action in mania is unknown.
INDICATIONS AND USAGE
Lithium is indicated i